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NG2 is a membrane spanning proteoglycan with a large extracellular domain show-
ing binding sites for several molecules, including extracellular matrix components 
and growth factors. In the developing CNS, NG2 is expressed by subpopulations of 
oligodendroglia precursors and additionally by microvascular pericytes. The expres-
sion of NG2 is downregulated in mature oligodendrocytes and also pericytes of stable 
brain vessels in healthy brains do not express the proteoglycan. Our previous studies 
have demonstrated that during human cerebral cortex development, ‘activated’ NG2-
pericytes form vascular cord that allow endothelial cell migration and elongation thus 
contributing to vascular sprouting. Braced by these first results, we have concentrated 
our attention on the possible involvement of NG2 and NG2-expressing cells on cell/
cell and cell/matrix relationships during vessel growth, in developing human brain at 9 
and 22 weeks of gestation. Double immunolabelling has been carried out utilizing anti-
NG2 antibodies directed against different antigenic sites of the core protein; namely, a 
rabbit anti-NG2 D2, mouse monoclonal antibodies from two different clones, F9 and 
D7, and a commercially available rabbit anti NG2 (CSPG4, Sigma). At the earlier devel-
opmental stage, NG2+ pericytes are already an integral part of the vessel wall and are 
involved, together with Glut+ endothelial cells, in basal lamina collagen type IV and VI 
deposition. In double immunolabelling with two different NG2 antibodies (D2/F9), the 
staining patterns almost completely overlap and also coincide with collagen type IV/VI 
distributions. Later on, NG2 D2 and NG2 F9 staining patterns are largely unrelated, D2 
appearing associated with both pericytes and vessel basal membrane, whereas NG2 F9 
is primarily restricted to pericytes. It is known that in ‘in vitro’ assay almost the entire 
ectodomain of NG2 can be released by proteolitic shedding. These observations support 
the concept that both membrane-bound and unbound NG2 forms are involved in ves-
sel growth, and that the released proteoglycan may contribute as an ECM substrate to 
endothelial cell migration and sprouting. 
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